Stoke Therapeutics Inc’s recently made public that its Director Kaye Edward M. MD unloaded Company’s shares for reported $90012.0 on Mar 18 ’25. In the deal valued at $8.67 per share,10,382 shares were sold. As a result of this transaction, Kaye Edward M. MD now holds 148,253 shares worth roughly $1.07 million.
Then, Kaye Edward M. MD sold 8,907 shares, generating $73,661 in total proceeds. Upon selling the shares at $8.27, the Director now owns 139,346 shares.
Before that, Ticho Barry sold 3,884 shares. Stoke Therapeutics Inc shares valued at $33,674 were divested by the CHIEF MEDICAL OFFICER at a price of $8.67 per share. As a result of the transaction, Ticho Barry now holds 63,962 shares, worth roughly $0.46 million.
Chardan Capital Markets initiated its Stoke Therapeutics Inc [STOK] rating to a Buy in a research note published on December 20, 2024; the price target was $24. TD Cowen also remained covering STOK and has increased its forecast on March 26, 2024 with a “an Outperform” recommendation from previously “Market perform” rating.
Price Performance Review of STOK
On Friday, Stoke Therapeutics Inc [NASDAQ:STOK] saw its stock fall -3.22% to $7.21. Over the last five days, the stock has lost -11.53%. Stoke Therapeutics Inc shares have fallen nearly -34.63% since the year began. Nevertheless, the stocks have fallen -29.93% over the past one year. While a 52-week high of $17.58 was reached on 02/05/25, a 52-week low of $7.18 was recorded on 03/28/25. SMA at 50 days reached $9.29, while 200 days put it at $12.20.
Levels Of Support And Resistance For STOK Stock
The 24-hour chart illustrates a support level at 7.02, which if violated will result in even more drops to 6.83. On the upside, there is a resistance level at 7.44. A further resistance level may holdings at 7.67. The Relative Strength Index (RSI) on the 14-day chart is 34.48, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -0.80, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 92.41%. Stochastics %K at 11.34% indicates the stock is a buying.
How much short interest is there in Stoke Therapeutics Inc?
A steep rise in short interest was recorded in Stoke Therapeutics Inc stocks on 2025-03-14, growing by 1.63 million shares to a total of 11.71 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 10.09 million shares. There was a rise of 13.89%, which implies that there is a positive sentiment for the stock.
